New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
10:02 EDTSREV, TDC, HME, BMRN, SKM, ESRX, AT, KBW, ENR, ASEIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Science & Engineering (ASEI) downgraded to Hold from Buy at Benchmark Co.... Atlantic Power (AT) downgraded to Hold from Buy at Desjardins... BioMarin (BMRN) downgraded to Hold from Buy at Brean Capital... Energizer (ENR) downgraded to Market Perform from Outperform at Bernstein... Express Scripts (ESRX) downgraded to Hold from Buy at Jefferies... Home Properties (HME) downgraded to Underperform from Sector Perform at RBC Capital... KBW, Inc. (KBW) downgraded to Market Perform from Outperform at JMP Securities... SK Telecom (SKM) downgraded to Neutral from Outperform at Credit Suisse... ServiceSource (SREV) downgraded to Equal Weight from Overweight at Morgan Stanley... Teradata (TDC) downgraded to Sector Perform from Outperform at FBN Securities.
News For ASEI;AT;BMRN;ENR;ESRX;HME;KBW;SKM;SREV;TDC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 24, 2014
09:20 EDTBMRNBioMarin says Prosensa deal does not reflect deterioration of pipeline
Subscribe for More Information
08:12 EDTBMRNSarepta rises after DMD competitor acquired at significant premium
Shares of Sarepta Therapeutics (SRPT) are up 9.5% to $17.23 in early pre-market trading after rival drugmaker Prosensa (RNA) agreed to be acquired by BioMarin (BMRN). BioMarin has offered to purchase all of the outstanding ordinary shares of Prosensa for $17.75 per share, for a total up front consideration of approximately $680M. In addition, two approximately $80M contingent milestones are payable for the approval of drisapersen in the U.S. and Europe. Drisapersen is Prosensa's lead exon-skipping drug candidate for treating Duchenne muscular dystrophy, or DMD. Sarepta is at work on eteplirsen, its own exon-skipping therapeutic candidate for the treatment of DMD. Prosensa closed trading Friday at $11.44 and are up about 65% to $18.90 in pre-market trading following the deal announcement.
06:44 EDTBMRNBioMarin to host conference call
Subscribe for More Information
06:02 EDTBMRNBioMarin agrees to purchase all shares of Prosensa for $17.75 per share
Subscribe for More Information
November 20, 2014
08:11 EDTATAtlantic Power management to meet with UBS
Subscribe for More Information
November 19, 2014
10:00 EDTENROn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:14 EDTENREnergizer initiated with a Neutral at BTIG
Subscribe for More Information
November 17, 2014
10:02 EDTASEIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CyrusOne (CONE) upgraded to Buy from Hold at Stifel... MGIC Investment (MTG) upgraded to Conviction Buy from Buy at Goldman... NuVasive (NUVA) upgraded to Outperform from Market Perform at Wells Fargo... Phillips 66 (PSX) upgraded to Outperform from Neutral at Credit Suisse... Pinnacle Foods (PF) upgraded to Buy from Hold at Deutsche Bank... Rayonier (RYN) upgraded to Outperform from Sector Perform at RBC Capital.. Thoratec (THOR) upgraded to Outperform from Market Perform at Wells Fargo... Volcano (VOLC) upgraded to Outperform from Neutral at Credit Suisse... Progressive Waste (BIN) upgraded to Neutral from Underperform at Macquarie... Clean Harbors (CLH) upgraded to Outperform from Neutral at Wedbush... McGraw Hill Financial (MHFI) upgraded to Buy from Hold at Benchmark Co... Chesapeake (CHK) upgraded to Outperform from Market Perform at Bernstein... American Science & Engineering (ASEI) upgraded to Fair Value from Sell at CRT Capital... Sony (SNE) upgraded to Overweight from Equal Weight at Morgan Stanley.
08:31 EDTSREVServiceSource names Christopher Carrington CEO, effective December 1
ServiceSource (SREV) announced that its Board of Directors named Christopher M. Carrington as the company’s next CEO, effective December 1. Concurrent with Carrington joining the company, Ashley Johnson, previously CFO and most recently Acting CEO, will assume the role of the company’s Chief Customer Officer, overseeing the customer-facing functions for ServiceSource. Simon Biddiscombe will remain the CFO for the business. Most recently, Carrington served as Executive Vice President of Global Delivery for SYKES Enterprises (SYKE).
08:22 EDTASEIAmerican Science & Engineering upgraded to Fair Value from Sell at CRT Capital
Subscribe for More Information
07:08 EDTSREVServiceSource to hold a summit
2014 Recurring Revenue Summit is being held in Napa Valley, CA on November 17-18.
November 14, 2014
16:39 EDTESRXBerkshire Hathaway gives quarterly update on stakes
Subscribe for More Information
14:53 EDTESRXCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
11:22 EDTASEIAmerican Science & Engineering management to meet with Benchmark Co.
Subscribe for More Information
10:00 EDTENROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:07 EDTENREnergizer downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded Energizer to Market Perform citing the recent rally in shares. Wells believes the Duracell sale prices suggests a lower, not higher valuation for shares. It sees a balanced risk/reward as current levels and keeps a $132-$137 price target range for Energizer.
06:13 EDTENREnergizer price target raised to $152 from $134 at Citigroup
Subscribe for More Information
November 13, 2014
14:50 EDTATLonestar Capital to shut down by mid-2015, WSJ reports
Subscribe for More Information
14:45 EDTATLonestar capital to shut down, DJ reports
Subscribe for More Information
09:47 EDTENREnergizer up 4% to $129.81 after Berkshire buys peer Duracell
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use